———–|———-|————|
Dosage Protocols for Research
Disclaimer: All dosage information is for research reference only. These compounds are not approved for human use.
CJC-1295 No DAC Dosage
CJC-1295 with DAC Dosage
Ipamorelin Dosage
The Standard CJC-1295 + Ipamorelin Stack
The most common research combination:
Hanpro Peptides offers a convenient CJC-1295 + Ipamorelin blend for combined research protocols.
Side Effects Comparison
CJC-1295 Side Effects (Research Observations)
Common:
Less common:
Ipamorelin Side Effects (Research Observations)
Common:
Less common:
Key Difference in Side Effect Profiles
Ipamorelin is generally considered to have a cleaner side effect profile because:
CJC-1295 vs Ipamorelin: Which to Choose?
Choose CJC-1295 If:
Choose Ipamorelin If:
Most Research Uses Both:
The majority of contemporary growth hormone peptide research uses CJC-1295 (No DAC) + Ipamorelin together, as this combination provides the most physiological and effective GH stimulation.
How to Reconstitute and Store
Reconstitution Guide
Storage Guidelines
Use our Peptide Calculator for precise dosing volume calculations.
Purity and Quality Standards
When sourcing CJC-1295 and Ipamorelin for research:
Hanpro Peptides provides third-party tested CJC-1295 and Ipamorelin with full CoA documentation, ensuring research-grade quality.
Related Growth Hormone Peptides
Explore these additional GH-related research compounds:
Frequently Asked Questions
Is CJC-1295 the same as Sermorelin?
No. While both are GHRH analogs, CJC-1295 is a modified version with increased stability and longer half-life. Sermorelin is the original 29-amino-acid fragment of natural GHRH.
Does Ipamorelin increase cortisol?
Compared to other GHRPs, Ipamorelin has minimal effect on cortisol and prolactin. This selectivity is one of its key advantages in research settings.
How long does it take to see IGF-1 increases?
In research studies, measurable IGF-1 elevation typically occurs within 2-4 weeks of consistent CJC-1295 + Ipamorelin administration, with peak effects at 6-8 weeks.
Can CJC-1295 with DAC be stacked with Ipamorelin?
Yes, but the timing differs. CJC-1295 with DAC is dosed once weekly, while Ipamorelin is dosed daily. Many researchers prefer CJC-1295 No DAC for stacking due to more predictable pulsatile release.
What is the best time to administer these peptides?
Common research timing includes: first thing in the morning (fasted), post-workout, and 30-60 minutes before bed. The before-bed dose leverages natural nocturnal GH release patterns.
*Disclaimer: This article is for educational and research informational purposes only. CJC-1295 and Ipamorelin are research-use-only compounds not approved for human or animal consumption. All dosage and protocol information is based on preclinical research and does not constitute medical advice.*
The CJC-1295 compound data file collects the sequence, molecular weight, CAS and the impurity routes worth watching for this compound on one page.
Related laboratory reference pages
For researchers cross-referencing growth hormone secretagogue comparison, these pages provide complementary technical detail: CJC-1295 without DAC laboratory specification, Ipamorelin laboratory specification, CJC-1295 + Ipamorelin combination reference, and CJC-1295 + Ipamorelin combination guide. All materials referenced are supplied for laboratory research use only and are not for human or veterinary use.
